BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2320181)

  • 1. Increased cathepsin B activity in human lung tumors.
    Krepela E; Kasafírek E; Novák K; Viklický J
    Neoplasma; 1990; 37(1):61-70. PubMed ID: 2320181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
    Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
    Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1997; 44(4):219-39. PubMed ID: 9473776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients.
    Lüthgens K; Ebert W; Trefz G; Gabrijelcic D; Turk V; Lah T
    Cancer Detect Prev; 1993; 17(3):387-97. PubMed ID: 8402725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
    Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
    Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of increased lung tumor tissue cathepsin B.
    Ebert W; Knoch H; Werle B; Trefz G; Muley T; Spiess E
    Anticancer Res; 1994; 14(3A):895-9. PubMed ID: 8074490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and tissue localization of cathepsin D in non small cell lung cancer.
    Chyczewski L; Płoński A; Chyczewska E; Furman M; Ostrowska H; Nikliński J; Kozłowski M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():217-29. PubMed ID: 9337539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B in tumors, normal tissue and isolated cells from the human lung.
    Werle B; Ebert W; Klein W; Spiess E
    Anticancer Res; 1994; 14(3A):1169-76. PubMed ID: 8074469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
    Rozhin J; Gomez AP; Ziegler GH; Nelson KK; Chang YS; Fong D; Onoda JM; Honn KV; Sloane BF
    Cancer Res; 1990 Oct; 50(19):6278-84. PubMed ID: 2400991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence demonstration of cathepsin B-like cysteine proteinase activity in lung squamous cell carcinomas and surrounding tissues.
    Kolár Z
    Acta Univ Palacki Olomuc Fac Med; 1986; 114():203-9. PubMed ID: 2946180
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity and tissue localization of cathepsin G in non small cell lung cancer.
    Maksimowicz T; Chyczewska E; Chyczewski L; Nikliński J; Ostrowska H; Szyszko J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():199-216. PubMed ID: 9337538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.
    Inoue T; Ishida T; Sugio K; Sugimachi K
    Cancer Res; 1994 Dec; 54(23):6133-6. PubMed ID: 7954459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
    Schweiger A; Staib A; Werle B; Krasovec M; Lah TT; Ebert W; Turk V; Kos J
    Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue.
    Werle B; Ebert W; Klein W; Spiess E
    Biol Chem Hoppe Seyler; 1995 Mar; 376(3):157-64. PubMed ID: 7612192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminopeptidases and angiotensin I-converting enzyme activities in primary human lung tumors and lung parenchyma.
    Procházka J; Krepela E; Sedo A; Viklický J; Fiala P
    Neoplasma; 1991; 38(5):501-8. PubMed ID: 1683470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
    Rozhin J; Robinson D; Stevens MA; Lah TT; Honn KV; Ryan RE; Sloane BF
    Cancer Res; 1987 Dec; 47(24 Pt 1):6620-8. PubMed ID: 2824039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful?
    Mori M; Kohli A; Baker SP; Savas L; Fraire AE
    Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
    Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS
    Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.